HGWM
PCVX icon

Harvest Group Wealth Management’s Vaxcyte PCVX Stock Holding History

Harvest Group Wealth Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$525 Buy
14
+8
+133% +$339 ﹤0.01% 166
2022
Q4 		$288 Buy
+6
New +$235 ﹤0.01% 179

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

Harvest Group Wealth Management's PCVX Position: Q1 2023 in Review

Harvest Group Wealth Management increased its Vaxcyte (PCVX) stake by 133% in Q1 2023, buying an estimated $339 and bringing the position to 14 shares worth $525. The position accounts for ﹤0.01% of the portfolio, ranked #166.

Harvest Group Wealth Management first reported a position in PCVX in Q4 2022 and has held it in 2 quarters since. 187 funds tracked by Wall St. Rank hold PCVX as of Q1 2023.

  • Harvest Group Wealth Management held 14 shares of Vaxcyte worth $525 as of Q1 2023.
  • Harvest Group Wealth Management bought 8 Vaxcyte shares in Q1 2023, an estimated $339.
  • Vaxcyte made up ﹤0.01% of Harvest Group Wealth Management's portfolio in Q1 2023, its #166 holding.
  • Harvest Group Wealth Management first reported a position in Vaxcyte in Q4 2022 and has held it in 2 quarters since.
  • 187 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2023.

Based on Harvest Group Wealth Management's 13F filing for Q1 2023, filed 28 Apr 2023.